Open AccessNivolumab & Relatlimab-Rmbw (Opdualag™)
Author(s) -
Janelle E. Mann
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000831944.05424.8d
Subject(s) - nivolumab , medicine , oncology , metastatic melanoma , melanoma , monoclonal antibody , antibody , cancer research , pharmacology , cancer , immunotherapy , immunology